Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.
Frequently asked questions
What sector does Epigenomics AG (EPGNF) operate in?
Epigenomics AG belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Epigenomics AG (EPGNF) current stock price?
As of the latest data, Epigenomics AG stock price is $1.12, with a previous close of $1.12.
What is Epigenomics AG (EPGNF) current market capitalization?
Epigenomics AG market cap is approximately 1.00 million.
What is Epigenomics AG (EPGNF) Earnings Per Share (EPS)?
The trailing EPS is -$3.37.
Does Epigenomics AG (EPGNF) pay dividends?
No. Epigenomics AG does not pay a dividend.
What is Epigenomics AG (EPGNF) beta (volatility) score?
Epigenomics AG has a beta of 0.900, meaning its volatility is roughly in line with the market.